Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ward

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
Journal of Managed Care & Specialty Pharmacy|February 4, 2020
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic ReviewThomas Ward, Daniel Sugrue, Olivia Hayward, et al.
Pharmacoeconomics - Open|August 4, 2022
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in IrelandThomas Ward, Tray Brown, Ruth D Lewis, et al.
The British Journal of Clinical Psychology|May 5, 2021
Relating behaviours and therapeutic actions during AVATAR therapy dialogue: An observational studyConan O'Brien, Mar Rus-Calafell, Tom Kj Craig, et al.
Psychology and Psychotherapy|October 5, 2023
Trauma therapies for psychosis: A state-of-the-art reviewAmy Hardy, Nadine Keen, David van den Berg, et al.
Psychological Medicine|April 5, 2021
Need for care, adversity exposure and perceived stress in clinical and healthy voice-hearers - CorrigendumDavid Baumeister, Thomas Ward, Philippa Garety, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1bPhil McEwan, Thomas Ward, Samantha Webster, et al.
Trials|August 14, 2015
The effects of an Audio Visual Assisted Therapy Aid for Refractory auditory hallucinations (AVATAR therapy): study protocol for a randomised controlled trialTom K J Craig, Mar Rus-Calafell, Thomas Ward, et al.
Schizophrenia Bulletin|May 7, 2020
AVATAR Therapy for Distressing Voices: A Comprehensive Account of Therapeutic TargetsThomas Ward, Mar Rus-Calafell, Zeyana Ramadhan, et al.
Clinical Drug Investigation|September 3, 2016
Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver DiseaseThomas Ward, Jason Gordon, Beverley Jones, et al.
Psychological Medicine|July 21, 2020
Need for care, adversity exposure and perceived stress in clinical and healthy voice-hearersDavid Baumeister, Thomas Ward, Philippa Garety, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Journal of Managed Care & Specialty Pharmacy|February 4, 2020
Estimating HIV Management and Comorbidity Costs Among Aging HIV Patients in the United States: A Systematic ReviewThomas Ward, Daniel Sugrue, Olivia Hayward, et al.
Pharmacoeconomics - Open|August 4, 2022
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in IrelandThomas Ward, Tray Brown, Ruth D Lewis, et al.
The British Journal of Clinical Psychology|May 5, 2021
Relating behaviours and therapeutic actions during AVATAR therapy dialogue: An observational studyConan O'Brien, Mar Rus-Calafell, Tom Kj Craig, et al.
Psychology and Psychotherapy|October 5, 2023
Trauma therapies for psychosis: A state-of-the-art reviewAmy Hardy, Nadine Keen, David van den Berg, et al.
Psychological Medicine|April 5, 2021
Need for care, adversity exposure and perceived stress in clinical and healthy voice-hearers - CorrigendumDavid Baumeister, Thomas Ward, Philippa Garety, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2015
Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1bPhil McEwan, Thomas Ward, Samantha Webster, et al.
Trials|August 14, 2015
The effects of an Audio Visual Assisted Therapy Aid for Refractory auditory hallucinations (AVATAR therapy): study protocol for a randomised controlled trialTom K J Craig, Mar Rus-Calafell, Thomas Ward, et al.
Schizophrenia Bulletin|May 7, 2020
AVATAR Therapy for Distressing Voices: A Comprehensive Account of Therapeutic TargetsThomas Ward, Mar Rus-Calafell, Zeyana Ramadhan, et al.
Clinical Drug Investigation|September 3, 2016
Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver DiseaseThomas Ward, Jason Gordon, Beverley Jones, et al.
Psychological Medicine|July 21, 2020
Need for care, adversity exposure and perceived stress in clinical and healthy voice-hearersDavid Baumeister, Thomas Ward, Philippa Garety, et al.
Pageof 19